In fiscal year 2025, SOOSAN CEBOTICS (017550) reported revenue of 229.4 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 229.4 billion KRW | 19.0 billion KRW | 15.8 billion KRW | [source] |
| 2024 | 197.9 billion KRW | 12.1 billion KRW | 9.2 billion KRW | [source] |
| 2023 | 226.5 billion KRW | 16.4 billion KRW | 16.9 billion KRW | [source] |
| 2022 | 286.3 billion KRW | 22.6 billion KRW | 15.7 billion KRW | [source] |
| 2021 | 253.0 billion KRW | 14.3 billion KRW | 11.4 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 236.3 billion KRW | 61.2 billion KRW | 175.1 billion KRW | [source] |
| 2024 | 216.3 billion KRW | 45.3 billion KRW | 171.0 billion KRW | [source] |
| 2023 | 184.2 billion KRW | 42.5 billion KRW | 141.7 billion KRW | [source] |
| 2022 | 181.5 billion KRW | 70.3 billion KRW | 111.2 billion KRW | [source] |
| 2021 | 169.1 billion KRW | 64.0 billion KRW | 105.2 billion KRW | [source] |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|---|---|---|---|
| 2025 | 8.7 billion KRW | -10.3 billion KRW | 9.0 billion KRW | [source] |
| 2024 | 23.2 billion KRW | -3.7 billion KRW | -35.1 billion KRW | [source] |
| 2023 | 21.4 billion KRW | -20.8 billion KRW | 7.7 billion KRW | [source] |
| 2022 | 1.6 billion KRW | -15.8 billion KRW | 8.2 billion KRW | [source] |
| 2021 | -467 million KRW | 20.6 billion KRW | -18.0 billion KRW | [source] |
